Investor directory
Advent Life Sciences
Advent Life Sciences' edge comes from its deep industry expertise and a collaborative partnership model with portfolio companies.
What they invest in
Sectors
Geographies
UKEuropeUSA
The facts
- Typical cheque
- €1M – €30M
- Headquarters
- London, United Kingdom
- Founded
- 1981
Portfolio
Centessa PharmaceuticalsBeacon TherapeuticsIterum Therapeutics (OTCM: ITRMF)Nalu MedicalAraviveAcutus Medical (OTCM: AFIB)F2GAura Biosciences (NAS: AURA)GlycomineProximieKaNDy TherapeuticsAviadoBioMoximedAxonicsArrakis TherapeuticsArgá MedtechNeRRe TherapeuticsArtax BiopharmaPIC TherapeuticsCyted HealthVestagenZikani TherapeuticsWondr MedicalCurve Therapeutics
and 9 more
Does Advent Life Sciences fit your round?
Oka scores this fund against your actual raise — stage, sector, cheque size and traction — and shows you who can introduce you.
Check your matchAre you Advent Life Sciences? Tell us what to correct and we will update it — or ask us to remove the entry.